Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Sep;38(9):1627–1643. doi: 10.1172/JCI103941

THE LYSIS OF ARTIFICIALLY INDUCED INTRAVASCULAR CLOTS IN MAN BY INTRAVENOUS INFUSIONS OF STREPTOKINASE*,†

Alan J Johnson 1,2, W Ross McCarty 1,2
PMCID: PMC293294  PMID: 14407413

Full text

PDF
1627

Images in this article

1628Image
on p.1628
1637Image
on p.1637
1638Image
on p.1638

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The activation of human plasminogen. II. A kinetic study of activation with trypsin, urokinase, and streptokinase. J Biol Chem. 1958 Jul;233(1):86–90. [PubMed] [Google Scholar]
  2. AMBRUS J. L., AMBRUS C. M., BACK N., SOKAL J. E., COLLINS G. L. Clinical and experimental studies on fibrinolytic enzymes. Ann N Y Acad Sci. 1957 Aug 30;68(1):97–137. doi: 10.1111/j.1749-6632.1957.tb42616.x. [DOI] [PubMed] [Google Scholar]
  3. BACH N., AMBRUS J. L., SIMPSON C. L., SHULMAN S. Study on the effect of streptokinase-activated plasmin (fibrinolysin) on clots in various stages of organization. J Clin Invest. 1958 Jun;37(6):864–871. doi: 10.1172/JCI103677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CLIFFTON E. E., GROSSI C. E., CANNAMELA D. Lysis of thrombi produced by sodium morrhuate in the femoral vein of dogs by human plasmin (fibrinolysin). Ann Surg. 1954 Jan;139(1):52–62. doi: 10.1097/00000658-195401000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CLIFFTON E. E. The use of plasmin in humans. Ann N Y Acad Sci. 1957 Aug 30;68(1):209–229. doi: 10.1111/j.1749-6632.1957.tb42627.x. [DOI] [PubMed] [Google Scholar]
  6. Christensen L. R. METHODS FOR MEASURING THE ACTIVITY OF COMPONENTS OF THE STREPTOCOCCAL FIBRINOLYTIC SYSTEM, AND STREPTOCOCCAL DESOXYRIBONUCLEASE. J Clin Invest. 1949 Jan;28(1):163–172. doi: 10.1172/JCI102045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FLETCHER A. P., ALKJAERSIG N., SMYRNIOTIS F. E., SHERRY S. The treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans Assoc Am Physicians. 1958;71:287–296. [PubMed] [Google Scholar]
  8. Fischel E. E., Pauli R. H., Lesh J. SEROLOGICAL STUDIES IN RHEUMATIC FEVER. II. SERUM COMPLEMENT IN THE RHEUMATIC STATE. J Clin Invest. 1949 Sep;28(5 Pt 2):1172–1181. doi: 10.1172/JCI102151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. GEIGER W. B. Involvement of a complement-like factor in the activation of blood protease. J Immunol. 1952 Dec;69(6):597–604. [PubMed] [Google Scholar]
  10. GORDON S., ABLONDI F. B. The effect of streptococcal enzymes and other agents on experimental inflammation. Ann N Y Acad Sci. 1957 Aug 30;68(1):89–96. doi: 10.1111/j.1749-6632.1957.tb42615.x. [DOI] [PubMed] [Google Scholar]
  11. JOHNSON A. J., FLETCHER A. P., MCCARTY W. R., TILLETT W. S. Effects in patients of intravenous infusions of purified streptokinase preparations. Proc Soc Exp Biol Med. 1957 Feb;94(2):254–258. doi: 10.3181/00379727-94-22913. [DOI] [PubMed] [Google Scholar]
  12. JOHNSON A. J., FLETCHER A. P., McCARTY W. R., TILLETT W. S. The intravascular use of streptokinase. Ann N Y Acad Sci. 1957 Aug 30;68(1):201–208. doi: 10.1111/j.1749-6632.1957.tb42626.x. [DOI] [PubMed] [Google Scholar]
  13. JOHNSON A. J., TILLETT W. S. The lysis in rabbits of intravascular blood clots by the streptococcal fibrinolytic system (streptokinase). J Exp Med. 1952 May 1;95(5):449–464. doi: 10.1084/jem.95.5.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KLINE D. L., FISHMAN J. B. Plasmin, the humoral protease. Ann N Y Acad Sci. 1957 Aug 30;68(1):25–37. doi: 10.1111/j.1749-6632.1957.tb42609.x. [DOI] [PubMed] [Google Scholar]
  15. LAKI K. The polymerization of proteins; the action of thrombin on fibrinogen. Arch Biochem Biophys. 1951 Jul;32(2):317–324. doi: 10.1016/0003-9861(51)90277-9. [DOI] [PubMed] [Google Scholar]
  16. MILLER J. M., SURMONTE J. A., GINSBERG M., ABLONDI F. B. Clinical experience with the injection of streptokinase intramuscularly in the treatment of infection and edema. Md State Med J. 1955 Apr;4(4):188–193. [PubMed] [Google Scholar]
  17. MULLERTZ S., LASSEN M. An activator system in blood indispensable for formation of plasmin by streptokinase. Proc Soc Exp Biol Med. 1953 Feb;82(2):264–268. doi: 10.3181/00379727-82-20087. [DOI] [PubMed] [Google Scholar]
  18. MULLERTZ S. The action of plasmin on fibrin and fibrinogen in blood. Acta Physiol Scand. 1953 Mar 31;28(1):29–40. doi: 10.1111/j.1748-1716.1953.tb00957.x. [DOI] [PubMed] [Google Scholar]
  19. NORMAN P. S., HILL B. M. Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma. J Exp Med. 1958 Nov 1;108(5):639–649. doi: 10.1084/jem.108.5.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PILLEMER L., RATNOFF O. D., BLUM L., LEPOW I. H. The inactivation of complement and its components by plasmin. J Exp Med. 1953 Apr;97(4):573–589. doi: 10.1084/jem.97.4.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. RATNOFF O. D. Studies on a proteolytic enzyme in human plasma. IX. Fibrinogen and fibrin as substrates for the proteolytic enzyme of plasma. J Clin Invest. 1953 Jun;32(6):473–479. doi: 10.1172/JCI102762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SCHWERT G. W., TAKENAKA Y. A spectrophotometric determination of trypsin and chymotrypsin. Biochim Biophys Acta. 1955 Apr;16(4):570–575. doi: 10.1016/0006-3002(55)90280-8. [DOI] [PubMed] [Google Scholar]
  23. SHERRY S., ALKJAERSIG N. Biochemical experimental, and clinical studies of proteolytic enzymes with particular reference to the fibrinolytic enzyme of human plasma. Ann N Y Acad Sci. 1957 Aug 30;68(1):52–66. doi: 10.1111/j.1749-6632.1957.tb42612.x. [DOI] [PubMed] [Google Scholar]
  24. SHERRY S., TITCHENER A., GOTTESMAN L., WASSERMAN P., TROLL W. The enzymatic dissolution of experimental arterial thrombi in the dog by trypsin, chymotrypsin and plasminogen activators. J Clin Invest. 1954 Oct;33(10):1303–1313. doi: 10.1172/JCI103006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. SHERRY S. The fibrinolytic activity of streptokinase activated human plasmin. J Clin Invest. 1954 Jul;33(7):1054–1063. doi: 10.1172/JCI102973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. TILLETT W. S., JOHNSON A. J., McCARTY W. R. The intravenous infusion of the streptococcal fibrinolytic principle (streptokinase) into patients. J Clin Invest. 1955 Feb;34(2):169–185. doi: 10.1172/JCI103071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. TILLETT W. S., SHERRY S. Streptococcal enzymatic debridement. Ann Surg. 1950 Jan;131(1):12-22, illust, pl. doi: 10.1097/00000658-195001000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. TILLETT W. S. Studies on the enzymatic lysis of fibrin and inflammatory exudates by products of hemolytic streptococci. Harvey Lect. 1949 1950;Series 45:149–210. [PubMed] [Google Scholar]
  29. Tillett W. S., Edwards L. B., Garner R. L. FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS. J Clin Invest. 1934 Jan;13(1):47–78. doi: 10.1172/JCI100579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tillett W. S., Sherry S. THE EFFECT IN PATIENTS OF STREPTOCOCCAL FIBRINOLYSIN (STREPTOKINASE) AND STREPTOCOCCAL DESOXYRIBONUCLEASE ON FIBRINOUS, PURULENT, AND SANGUINOUS PLEURAL EXUDATIONS. J Clin Invest. 1949 Jan;28(1):173–190. doi: 10.1172/JCI102046. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES